So, even treated with prophylactic lamivudine or after withdrawal, cancer patients who are chronic HBV infected or HBV carriers should be closely checked for serum HBV DNA levels and liver function (ALT) during and after chemotherapy (54). This evidence concerns the gene GPT and cancer.